SON is an essential m6A target for hematopoietic stem cell fate

Authors:

Abstract
No abstract available
Funding Information
  • AbbVie
  • Memorial Sloan-Kettering Cancer Center
  • New York State Stem Cell Science (C32599GG)
  • NIDDK (K99 DK128602-01, R01-DK101989-01A1)
  • AstraZeneca
  • Leukemia and Lymphoma Society
  • Howard Hughes Medical Institute
  • National Heart, Lung, and Blood Institute (R01 CA236911, R01 HL168659, R01HL157387-01A1)
  • NHGRI (R01 HG013328-01A1)
  • NCI (NCI P30 CA 008748, R01 CA274249-01A1, R01CA225231-01, R01HL135564)
  • National Institutes of Health

This publication has 99 references indexed in Scilit: